These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 30654237)
1. Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles. Caneschi W; Enes KB; Carvalho de Mendonça C; de Souza Fernandes F; Miguel FB; da Silva Martins J; Le Hyaric M; Pinho RR; Duarte LM; Leal de Oliveira MA; Dos Santos HF; Paz Lopes MT; Dittz D; Silva H; Costa Couri MR Eur J Med Chem; 2019 Mar; 165():18-30. PubMed ID: 30654237 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents. Bajaj S; Roy PP; Singh J Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. Kumar D; Patel G; Johnson EO; Shah K Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel furo[2,3-d]pyrimidin-2-one-1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis. El Mansouri AE; Oubella A; Dânoun K; Ahmad M; Neyts J; Jochmans D; Snoeck R; Andrei G; Morjani H; Zahouily M; Lazrek HB Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100146. PubMed ID: 34128255 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents. Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity. Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives. Du K; Cao X; Zhang P; Zheng H Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors. Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid. Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors. Sun J; Ren SZ; Lu XY; Li JJ; Shen FQ; Xu C; Zhu HL Bioorg Med Chem; 2017 May; 25(9):2593-2600. PubMed ID: 28363444 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors. Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides. Avanzo RE; Padrón JM; D'Accorso NB; Fascio ML Bioorg Med Chem Lett; 2017 Aug; 27(16):3674-3677. PubMed ID: 28716494 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents. Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Molecular Docking Study, and Cytotoxic Activity of 3,4-diaryl-5-(4-pyridinyl)-1,2,4-oxadiazole. Zareian B; Ghadbeighi S; Amirhamzeh A; Ostad SN; Shafiee A; Amini M Med Chem; 2016; 12(4):394-401. PubMed ID: 26558375 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, quantitative structure-activity relationship and biological evaluation of 1,3,4-oxadiazole derivatives possessing diphenylamine moiety as potential anticancer agents. Abdel Rahman DE Chem Pharm Bull (Tokyo); 2013; 61(2):151-9. PubMed ID: 23370194 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2. Hamdy R; Elseginy SA; Ziedan NI; El-Sadek M; Lashin E; Jones AT; Westwell AD Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]